Insider · CIK 0001612903
Thomas Anderson
Files at ZVRA (ZEVRA THERAPEUTICS, INC.). First filing -, latest -.
In brief
Thomas Anderson files SEC Form 4 as director at ZVRA (ZEVRA THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas Anderson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 18, 2026 |
| May 29, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | May 30, 2025 |
Questions about Thomas Anderson
Answered from the filings on this page, as of the latest one.
Is Thomas Anderson buying or selling?
Thomas Anderson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas Anderson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas Anderson has 0.
Where does Thomas Anderson file Form 4?
Thomas Anderson has filed Form 4 at ZVRA (ZEVRA THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.